Third drug approved for metastatic, treatment-resistant GISTFebruary 27, 2013GastroenterologySarcoma & GISTGastrointestinal Cancer
Colorectal cancer subtype associated with obesity, inactivityFebruary 27, 2013GastroenterologyPreventive CareGastrointestinal Cancer
FOLFOXIRI bests FOLFIRI when bevacizumab is added in colorectal cancerFebruary 25, 2013GastroenterologyGastrointestinal Cancer
Selective resection feasible for esophageal cancerFebruary 25, 2013GastroenterologyGastrointestinal Cancer
Racial gap in gastric cancer survival narrows at 3 yearsFebruary 14, 2013GastroenterologyGastrointestinal Cancer
Capecitabine chemoradiotherapy effective in local pancreatic cancerFebruary 14, 2013GastroenterologyGastrointestinal Cancer
Survival shorter in young gastric cancer patientsFebruary 14, 2013GastroenterologyGastrointestinal Cancer
Screen asymptomatic siblings of CRC patientsFebruary 11, 2013GastroenterologyPreventive CareGastrointestinal Cancer
Gene profiling predicted responses to colorectal, pancreatic cancer treatmentFebruary 11, 2013GastroenterologyGastrointestinal Cancer
Japanese study: S-1 adjuvant chemo improved pancreatic cancer survivalFebruary 11, 2013GastroenterologyGastrointestinal Cancer
Add-on nab-paclitaxel extends survival in metastatic pancreatic cancerFebruary 5, 2013GastroenterologyGastrointestinal Cancer
Statins may reduce mortality in hepatocellular cancerFebruary 5, 2013GastroenterologyGastrointestinal Cancer
Bevacizumab boosts capecitabine response in elderly with metastatic colorectal cancerFebruary 4, 2013GastroenterologyGastrointestinal Cancer
Adding cetuximab to chemoradiotherapy harmful in esophageal cancerFebruary 1, 2013Head & Neck/Thyroid CancersGastroenterologyGastrointestinal Cancer
